Dexcom (DXCM) Capital Expenditures Growth (3y) (2013 - 2026)
Dexcom (DXCM) Capital Expenditures Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.86 Bn | 176.56 Bn | 6.27 Bn | 1.64% |
| 2 | Stryker | 128.65 Bn | 125.78 Bn | 3.81 Bn | 8.49% |
| 3 | Medtronic | 108.75 Bn | 99.53 Bn | 6.41 Bn | 8.89% |
| 4 | Boston Scientific | 68.34 Bn | 66.89 Bn | 3.61 Bn | 16.83% |
| 5 | Edwards Lifesciences | 48.33 Bn | 44.65 Bn | 1.29 Bn | 1.81% |
| 6 | GE HealthCare Technologies | 28.35 Bn | 26.07 Bn | 1.98 Bn | 7.57% |
| 7 | Dexcom | 28.33 Bn | 27.21 Bn | 750.30 Mn | 0.84% |
| 8 | Smith & Nephew | 26.90 Bn | 26.32 Bn | - | - |
| 9 | Koninklijke Philips | 25.45 Bn | 22.33 Bn | 2.07 Bn | 2.15% |
| 10 | Steris | 21.55 Bn | 21.11 Bn | 697.10 Mn | 8.08% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.84% |
| Dec 31, 2025 | 17.08% |
| Sep 30, 2025 | -9.39% |
| Jun 30, 2025 | 0.94% |
| Mar 31, 2025 | -5.04% |
| Dec 31, 2024 | 15.82% |
| Sep 30, 2024 | 0.95% |
| Jun 30, 2024 | -13.24% |
| Mar 31, 2024 | -17.05% |
| Dec 31, 2023 | -4.46% |
| Sep 30, 2023 | 2.07% |
| Jun 30, 2023 | 0.46% |
| Mar 31, 2023 | 31.04% |
| Dec 31, 2022 | 12.92% |
| Sep 30, 2022 | 29.61% |
| Jun 30, 2022 | 24.95% |
| Mar 31, 2022 | 37.25% |
| Dec 31, 2021 | 65.48% |
| Sep 30, 2021 | 65.61% |
| Jun 30, 2021 | 114.18% |